TWiV 1034: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses the immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate, association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers; effect of COVID-19 vaccination and booster on maternal-fetal outcomes, dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA, does monoclonal antibody treatment for COVID-19 impact short and long- term outcomes in a large generalizable population, persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation, core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a influenza A vaccine candidate (The Lancet) Association between nose picking and SARS-CoV-2 incidence (PLOSONE) Effect of COVID-19 vaccination and booster on maternal-fetal outcomes (Lancet Digital Health) Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status (The Lancet) Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes (BMJ) Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and inflammation (Angiogenesis) Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts (STM) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1034 Dr. Griffin's COVID treatment summary ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]